Xenon Pharmaceuticals XENE Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's quick ratio?
- Xenon Pharmaceuticals (XENE) reported quick ratio of 27.8× in Q1 2026.
- How has Xenon Pharmaceuticals's quick ratio changed year-over-year?
- Xenon Pharmaceuticals's quick ratio increased by 57.4% year-over-year, from 17.7× to 27.8×.
- What is the long-term trend for Xenon Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's quick ratio has grown at a 1.8% compound annual growth rate (CAGR), from 12.3× to 13.4×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.